Rationale for Early Discontinuation of Aspirin After Transcatheter Aortic Valve Implantation: Design of the SOLOTAVI Randomized Trial. // American Heart Journal. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002966?dgcid=rss_sd_all
Rationale for Early Discontinuation of Aspirin After Transcatheter Aortic Valve Implantation: Design of the SOLOTAVI Randomized Trial. American Heart Journal. https://www.sciencedirect.com/science/article/pii/S0002870326002966?dgcid=rss_sd_all
“Rationale for Early Discontinuation of Aspirin After Transcatheter Aortic Valve Implantation: Design of the SOLOTAVI Randomized Trial.” American Heart Journal.
@article{article93088,
title = {Rationale for Early Discontinuation of Aspirin After Transcatheter Aortic Valve Implantation: Design of the SOLOTAVI Randomized Trial},
journal = {American Heart Journal},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002966?dgcid=rss_sd_all}
}